GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VBI Vaccines Inc (OTCPK:SVACD) » Definitions » Margin of Safety % (DCF FCF Based)

VBI Vaccines (VBI Vaccines) Margin of Safety % (DCF FCF Based) : N/A (As of May. 17, 2024)


View and export this data going back to . Start your Free Trial

What is VBI Vaccines Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

VBI Vaccines's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


Competitive Comparison of VBI Vaccines's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, VBI Vaccines's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VBI Vaccines's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VBI Vaccines's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where VBI Vaccines's Margin of Safety % (DCF FCF Based) falls into.



VBI Vaccines Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of VBI Vaccines's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


VBI Vaccines (VBI Vaccines) Business Description

Industry
Traded in Other Exchanges
Address
160 Second Street, Floor 3, Cambridge, MA, USA, 02142
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.

VBI Vaccines (VBI Vaccines) Headlines

From GuruFocus

VBI Vaccines to Participate in Upcoming Investor Conferences

By Business Wire Business Wire 11-14-2022

VBI Vaccines Announces Results of Annual General Meeting

By Business Wire Business Wire 06-22-2022